Hosted on MSN16h
Colgate Advances 13% in a Year: To Buy or Not to Buy the Stock?Colgate-Palmolive Company CL shares have appreciated 13.1% in the trailing 12 months, outperforming the Zacks Consumer ...
In a report released on January 15, Nik Modi from RBC Capital maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a ...
Colgate-Palmolive Co (CL) stock saw a modest uptick, ending the day at $88.56 which represents a slight increase of $0.70 or 0.80% from the prior close of $87.86. The stock opened at $87.6 and touched ...
There is more to the comparison, and in the sections below, we discuss why we think CL will outperform KMB in the next three ...
Colgate-Palmolive's US$88.56 share price signals that it might be 42% undervalued Analyst price target for CL is US$102 which is 34% below our fair value estimate ...
Colgate-Palmolive Co (CL) stock saw a decline, ending the day at $86.36 which represents a decrease of $-1.10 or -1.26% from the prior close of $87.46. The stock opened at $86.51 and touched a low of ...
Shares of Colgate-Palmolive Co. CL slipped 1.26% to $86.36 Friday, on what proved to be an all-around grim trading session ...
Procter & Gamble and Colgate-Palmolive are among the defendants in six new lawsuits targeting the sale of toothpaste and ...
BSM Partners, the largest full-service pet care research, consulting, and strategy-to-shelf product innovation firm, is excited to announce that Bob Riebe has been appointed Chief Operating and Sales ...
Colgate-Palmolive Co. closed $22.20 short of its 52-week high ($109.30), which the company reached on September 5th.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback